The American College of Rheumatology (ACR) today commended leaders in the United States Senate for introducing the bipartisan Safe Step Act of 2021 (S. 464), new legislation that would place reasonable limits on insurer use of step therapy.
McInnes and colleagues have published the results of the SELECT - PsA trial in NEJM showing updacitinib (UPA) to be superior to placebo in active psoriatic arthritis (PsA) patients, with 15 mg UPA equal to adalimumab (ADA) and 30 mg UPA qd being superior to ADA.
Dr. John Cush RheumNow
5 years 6 months ago
News Feature: Hypertension Unaffected by Urate Lowering Therapy
Does uric acid contribute to the risk of hypertension (HTN)? A recent cohort trial shows that allopurinol in young adults does not sufficiently lower blood pressure (BP).
https://t.co/PAMkgCc2DS #RheumNow https://t.co/ar7OiWKVQj
Dr. John Cush RheumNow
5 years 6 months ago
263 RA patients with ILD were treated w/ Abatacept (ABA mono, ABA+MTX or ABA+nonMTX) - all improved their DAS28, stablized their FVC, DLCO, CHest CT; Only difference was that steroid sparing best when ABA used in combo. https://t.co/11vJCWOdSG https://t.co/yMF6imuFMV
Dr. John Cush RheumNow
5 years 6 months ago
Abstract presented 10/20 at American Society Nephrology mtg show IV Pegloticase use in 136 ESRD dialysis pts (Rx by Rheums 68%). Pts were 73% males, avg age 57 years, More on hemodialysis [79%] than peritoneal dialysis [17%]. Pts RCV ~13 infusions. https://t.co/SFO8duqiy8
Dr. John Cush RheumNow
5 years 6 months ago
Great coverage of #RNL2021 from Dr. Robert Chao @doctorRBC
Fascinating talk by Dr. Robert Wang on uveitis. Pearls:
-Anterior uveitis with hypopyon, will be B27+
-Hypopyon can be 2/2 Behcets and endopthalmitis
-work up for Uveitis: B27, ACE/CXR, syphilis test
#RNL2021 https://t.co/9DdNaAt7lx
Dr. John Cush RheumNow
5 years 6 months ago
News Feature: Psoriatic Disease Management - #RNL2021 Highlights
This year’s coverage of psoriatic arthritis included an overview of the latest therapeutic options, a discussion on psoriasis specifically, and the epidemiology of psoriatic arthritis.
https://t.co/wJ0pFgANhy https://t.co/SJezq1O7T4
The European Journal of Preventive Cardiology reports that younger patients with their first myocardial infarction before age 50 yrs have a higher risk of having a systemic inflammatory disease (SIDs) and higher rates all-cause mortality.
Dr. John Cush RheumNow
5 years 6 months ago
The Reflecting Rheum: Top Publications from 2020 Covering SpA and Still’s Disease
Sponsored by Novartis Medical Affairs
Listen to a panel of experts share their views on top spondyloarthritis and Still’s disease publications from 2020.
View Now: https://t.co/Kp2drDS1x3 https://t.co/Y1PilF0Syg
Dr. John Cush RheumNow
5 years 6 months ago
From Dr. Petryna ( @DrPetryna ) on Pneumonia & RA #RNL2021 :
-PNA most common hospital inf in RA and main cause of hosp mortality
-seropositivity assoc w/increase risk of PNA
-COPD+RA bad combo: increase PNA & mortality
#RheumNow https://t.co/IgXfJTMrcn
Dr. John Cush RheumNow
5 years 6 months ago
Have you listened to this week's podcast?
Dr. Jack Cush reviews the news, FDA Denials and journal articles from the past week on RheumNow.
Download wherever podcasts are available.
https://t.co/Twy04G9RU1 https://t.co/NSsR2tFq5i
The Spondyloarthritis Advances pod presented during the RheumNow Live 2021 conference featured three speakers, including an excellent lecture by Dr. Robert Wang, ophthalmology, on HLA B27 iritis and practical tips for rheumatologists.
I interviewed Dr. Wang and below are his five best pearls for HLA B27 iritis that you need to know for your clinical practice.
Dr. John Cush RheumNow
5 years 6 months ago
Metanalysis of 32 studies shows most forms of arthritis assoc w/ incr risk of CVA (ischemic stroke: RR=1.53 or hemorrhagic stroke: RR=1.45), esp for RA (RR=1.38), AS (RR=1.49), PsA (RR=1.33), gout (RR=1.4) --risk higher with age <45 years (RR=1.46) https://t.co/YDiebrqtbi
Dr. John Cush RheumNow
5 years 6 months ago
From @KDAO2011 for #RNL2021
Is it better to taper the steroids or leave it?
SEMIRA study. Tapering off low dose steroids cause more flares and more treatment side effects.
Dr. Buttgereit says keep your low dose steroids (prednisone 5 mg/day or less)
https://t.co/FpQnxUKWwF
Dr. John Cush RheumNow
5 years 6 months ago
News Feature: Serious Infections Still Common in Vasculitis
Serious infections occurred more frequently among patients with ANCA-associated vasculitis who were given induction therapy with cyclophosphamide compared with rituximab (Rituxan). #RheumNow
https://t.co/dTL6cReg8s https://t.co/U2sbEzd5DX
